Thomas Friebe

466 total citations
8 papers, 419 citations indexed

About

Thomas Friebe is a scholar working on Molecular Biology, Physiology and Physiology. According to data from OpenAlex, Thomas Friebe has authored 8 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Physiology and 3 papers in Physiology. Recurrent topics in Thomas Friebe's work include Receptor Mechanisms and Signaling (8 papers), Adenosine and Purinergic Signaling (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). Thomas Friebe is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Adenosine and Purinergic Signaling (3 papers) and Nitric Oxide and Endothelin Effects (3 papers). Thomas Friebe collaborates with scholars based in Germany and Belgium. Thomas Friebe's co-authors include E. Mutschler, Günter Lambrecht, Hans G. Bäumert, Caren Hildebrandt, Ulrike Grimm, Ursula Windscheif, Reinhold Tacke, G. Lambrecht, Manfrid Eltze and Ulrich Moser and has published in prestigious journals such as British Journal of Pharmacology, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Thomas Friebe

8 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Friebe Germany 7 222 195 114 87 80 8 419
Ulrike Grimm Germany 4 226 1.0× 160 0.8× 96 0.8× 87 1.0× 68 0.8× 6 360
U. Braam Germany 8 161 0.7× 185 0.9× 60 0.5× 63 0.7× 68 0.8× 18 404
Ursula Windscheif Germany 6 383 1.7× 137 0.7× 83 0.7× 147 1.7× 109 1.4× 7 488
Jill Coates United Kingdom 10 156 0.7× 164 0.8× 92 0.8× 25 0.3× 80 1.0× 17 334
Judith E. Colby United States 7 122 0.5× 207 1.1× 139 1.2× 55 0.6× 108 1.4× 8 384
Valerie L. Saville United Kingdom 8 112 0.5× 158 0.8× 156 1.4× 74 0.9× 139 1.7× 10 369
Chaoying Li United States 7 143 0.6× 191 1.0× 167 1.5× 94 1.1× 32 0.4× 7 355
Che C. Huang United States 3 262 1.2× 198 1.0× 150 1.3× 25 0.3× 44 0.6× 12 355
Jonathan A. Roberts United Kingdom 13 618 2.8× 445 2.3× 98 0.9× 259 3.0× 73 0.9× 16 792
Lorna A. Meldrum United Kingdom 9 183 0.8× 304 1.6× 292 2.6× 119 1.4× 243 3.0× 12 634

Countries citing papers authored by Thomas Friebe

Since Specialization
Citations

This map shows the geographic impact of Thomas Friebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Friebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Friebe more than expected).

Fields of papers citing papers by Thomas Friebe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Friebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Friebe. The network helps show where Thomas Friebe may publish in the future.

Co-authorship network of co-authors of Thomas Friebe

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Friebe. A scholar is included among the top collaborators of Thomas Friebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Friebe. Thomas Friebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Augelli‐Szafran, Corinne E., et al.. (1997). Functional characterisation of PD102807: A novel M4-selective muscarinic antagonist. Life Sciences. 60(13-14). 1168–1168. 6 indexed citations
2.
Waelbroeck, Magalì, et al.. (1996). Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes. British Journal of Pharmacology. 119(7). 1319–1330. 23 indexed citations
3.
Tacke, Reinhold, Daiyo Terunuma, Magalì Waelbroeck, et al.. (1995). Fluorine-containing derivatives of the muscarinic antagonists sila-pridinol and sila-difenidol: Syntheses and antimuscarinic properties. Journal of Organometallic Chemistry. 501(1-2). 145–154. 6 indexed citations
4.
Eltze, Manfrid, E. Mutschler, Ulrich Moser, et al.. (1993). Characterization of muscarinic receptorsmediating vasodilation in rat perfused kidney. European Journal of Pharmacology. 238(2-3). 343–355. 42 indexed citations
5.
Eltze, Manfrid, E. Mutschler, Ulrich Moser, et al.. (1993). Characterization of the vasodilatory muscarinic receptor in perfused rat kidney by the use of agonists and antagonists. Life Sciences. 52(5-6). 579–579. 2 indexed citations
6.
Lambrecht, Günter, Thomas Friebe, Ulrike Grimm, et al.. (1992). PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. European Journal of Pharmacology. 217(2-3). 217–219. 274 indexed citations
7.
Tacke, Reinhold, et al.. (1991). Cyclohexy (4-fluorophenyl)(3-piperidinopropyl)silanol ((itp)-fluoro-hexahydro-sila-difenidol, p-F-HSSiD) and derivatives: synthesis and antimuscarinic properties. Journal of Organometallic Chemistry. 417(3). 339–353. 12 indexed citations
8.
Friebe, Thomas, et al.. (1990). Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(3). 284–9. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026